Chiome Bioscience, Chugai Pharma Terminate Partnership

Roche Could Take a $500M Hit Over Patent Losses

Roche Could Take a $500M Hit Over Patent Losses

Chiome Bioscience says it announces termination of candidate antibody related joint research contract, which was signed between the co and Chugai Pharma, as the contract has expired on Dec. 31

Dec 18 (Reuters) - Chiome Bioscience

* Says it announces termination of candidate antibody related joint research contract, which was signed between the co and Chugai Pharmaceutical Co., Ltd., as the contract has expired on Dec. 31

MORE ON THIS TOPIC